Dx & Vx Co., Ltd. (KOSDAQ:180400)
2,305.00
+15.00 (0.66%)
At close: Aug 11, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
Healthcare | 31.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Healthcare Growth | -20.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Diagnosis | 2.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Diagnosis Growth | -69.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
New Testament | 86.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
New Testament Growth | 89.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bio Healthcare - Manufactured Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bio Healthcare - Manufactured Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bio Healthcare - Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Bio Healthcare - Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
South Korea | 22.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -2.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 11.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 50.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 8.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -99.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|